Adenocarcinoma of the esophagus and gastroesophageal junction: The evolving treatment landscape for locally advanced and metastatic disease in the era of immune checkpoint inhibitors and biomarker‐driven therapeutics

Laura V. M. Baum; Kimberly L. Johung; Joanna Gibson; Gabriel Cartagena; Daniel J. Boffa; Jill Lacy

doi:10.3322/caac.70050

Adenocarcinoma of the esophagus and gastroesophageal junction: The evolving treatment landscape for locally advanced and metastatic disease in the era of immune checkpoint inhibitors and biomarker‐driven therapeutics

L Laura V. M. Baum (Deparment of Medicine Section of Medical Oncology Yale School of Medicine New Haven Connecticut USA) K Kimberly L. Johung (Department of Therapeutic Radiology Yale School of Medicine New Haven Connecticut USA) J Joanna Gibson (Department of Pathology Yale School of Medicine New Haven Connecticut USA) G Gabriel Cartagena (Deptartment of Psychiatry Yale School of Medicine New Haven Connecticut USA) D Daniel J. Boffa (Department of Surgery Section of Thoracic Surgery Yale School of Medicine New Haven Connecticut USA) J Jill Lacy (Deparment of Medicine Section of Medical Oncology Yale School of Medicine New Haven Connecticut USA)

Download PDF View Original

APA MLA Chicago BibTeX RIS

Article Details

Journal CA: A Cancer Journal for Clinicians

Volume / Issue Vol. 76, Issue 1

Published January 01, 2026

DOI 10.3322/caac.70050

ISSN 0007-9235

Publisher Wiley

Journal Info

CA: A Cancer Journal for Clinicians

Wiley

ISSN: 0007-9235 Open Access Q1 Medicine

Authors (6)

L

Laura V. M. Baum

Deparment of Medicine Section of Medical Oncology Yale School of Medicine New Haven Connecticut USA

K

Kimberly L. Johung

Department of Therapeutic Radiology Yale School of Medicine New Haven Connecticut USA

J

Joanna Gibson

Department of Pathology Yale School of Medicine New Haven Connecticut USA

G

Gabriel Cartagena

Deptartment of Psychiatry Yale School of Medicine New Haven Connecticut USA

D

Daniel J. Boffa

Department of Surgery Section of Thoracic Surgery Yale School of Medicine New Haven Connecticut USA

J

Jill Lacy

Deparment of Medicine Section of Medical Oncology Yale School of Medicine New Haven Connecticut USA

Adenocarcinoma of the esophagus and gastroesophageal junction: The evolving treatment landscape for locally advanced and metastatic disease in the era of immune checkpoint inhibitors and biomarker‐driven therapeutics

Article Details

Journal Info

Authors (6)

Related Articles from this Journal

Systemic amyloid light‐chain amyloidosis beyond ANDROMEDA: Diagnostic challenges and therapeutic updates

Screening for colorectal cancer

Correction to “Integrating multimodal management and molecular profiling in a patient with BRAF V600E–positive melanoma and brain metastases”

Blood tests for colorectal cancer—Hype ahead of evidence?

Medullary thyroid carcinoma and <i>RET</i> molecular testing: A virtual tumor board on clinical decision‐making